Neuralink's second human brain implant lined up despite 'issues'

The Food and Drug Administration (FDA) has allowed Elon Musk-owned Neuralink to implant one of its wireless brain chips in another human, despite reports of a malfunctioning device in the first receiver, reported Daily Mail.

Elon Musk’s company secured the green light from the FDA after resolving the issues faced by the 29-year-old first patient

In a blog post earlier this month, the California-based company wrote that many threads have retracted from Noland Arbaugh’s brain, according to CNBC.

Elon Musk’s tech venture plans to cure paralysis with the help of its brain-computer interface (BCI) helping the people to control external technology with their minds.

On Neuralink's website, a post read that the system is called the Link, which is capable of recording signals with the help of 1,024 electrodes across 64 "threads" that are thinner than human hair.

In January, the 2016-founded company experimented with its first implant in Arbaugh, and his video was also live-streamed in March in which he was observed playing chess with his BCI brain.

Neuralink said in April that the surgery went “extremely well.”

However, after successful surgery, Neuralink reported retraction of threads rendering fewer effective electrodes, which disrupted the company’s ability to determine Link’s speed and accuracy.

The post read: "Neuralink modified the recording algorithm, enhanced the user interface and worked to improve techniques for translating signals into cursor movements."